Abstract
High-throughput screening still has a long way to go if it is to achieve its often-touted potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kell, D. Screensavers: trends in high-throughput analysis. Trends Biotechnol. 17, 89–91 (1999).
Archer, R. Towards the drug discovery factory. J. Assoc. Lab. Automat. 3, 4 (1998).
Frederickson, R. Macromolecular matchmaking: advances in two-hybrid and related technologies. Curr. Opin Biotechnol. 9, 90– 96 (1998).
Young, K. et al. Identification of a calcium channel modulator using a high-throughput yeast two-hybrid screen. Nat. Biotechnol. 16, 946–950 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dove, A. Drug screening—beyond the bottleneck. Nat Biotechnol 17, 859–863 (1999). https://doi.org/10.1038/12845
Issue Date:
DOI: https://doi.org/10.1038/12845
This article is cited by
-
Bigger is better in virtual drug screens
Nature (2019)
-
Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactor
Nature Biomedical Engineering (2017)
-
One-step pipetting and assembly of encoded chemical-laden microparticles for high-throughput multiplexed bioassays
Nature Communications (2014)
-
Single-cell analysis and sorting using droplet-based microfluidics
Nature Protocols (2013)
-
A 3-D microfluidic combinatorial cell array
Biomedical Microdevices (2011)
